Heligenics Overview

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

Heligenics General Information

Description

Developer of a protein engineering platform designed to identify and optimize therapeutic proteins for drug development. The company offers high-throughput screening of protein variants, protein function data, and computational analysis, enabling biopharmaceutical companies and researchers to develop antibodies, interferons, and peptide-based therapeutics for cancer, autoimmune diseases, and metabolic disorders.

Contact Information

Formerly Known As
Heligenics LLC
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10530 Discovery Drive
  • Las Vegas, NV 89135
  • United States
+1 (209)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 10530 Discovery Drive
  • Las Vegas, NV 89135
  • United States
+1 (209)

Heligenics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Heligenics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator Completed Startup
5. Later Stage VC 08-Jan-2025 Completed Startup
4. Grant 02-Feb-2023 Completed Startup
3. Seed Round 23-Aug-2022 Completed Startup
2. Seed Round 15-Dec-2020 $1.18M $1.18M Completed Startup
1. Grant 01-Jan-2015 $2.5M Completed Startup
To view Heligenics’s complete valuation and funding history, request access »

Heligenics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed
To view Heligenics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Heligenics Patents

Heligenics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025236991-A1 Glycosylated engineered interferon beta proteins Pending 15-Mar-2024
WO-2025194144-A2 Glycosylated engineered interferon beta proteins Pending 15-Mar-2024
WO-2025194144-A3 Glycosylated engineered interferon beta proteins Pending 15-Mar-2024
AU-2024341598-A1 Engineered interferon-beta proteins Pending 12-Sep-2023
EP-4777131-A2 Engineered interferon-beta proteins Pending 12-Sep-2023 C07K14/565
To view Heligenics’s complete patent history, request access »

Heligenics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Heligenics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
City of Las Vegas Government Minority
University of Nevada, Las Vegas Foundation University Minority
Battle Born Venture Venture Capital Minority
Nevada Governor's Office of Economic Development Government
Roseman Bioventures Accelerator/Incubator
To view Heligenics’s complete investors history, request access »

Heligenics FAQs

  • Where is Heligenics headquartered?

    Heligenics is headquartered in Las Vegas, NV.

  • What is the size of Heligenics?

    Heligenics has 7 total employees.

  • What industry is Heligenics in?

    Heligenics’s primary industry is Drug Discovery.

  • Is Heligenics a private or public company?

    Heligenics is a Private company.

  • What is Heligenics’s current revenue?

    The current revenue for Heligenics is .

  • How much funding has Heligenics raised over time?

    Heligenics has raised $5.97M.

  • Who are Heligenics’s investors?

    City of Las Vegas, University of Nevada, Las Vegas Foundation, Battle Born Venture, Nevada Governor's Office of Economic Development, and Roseman Bioventures have invested in Heligenics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process